The effect of acenocoumarol on hemorheological parameters

Clinical Hemorheology and Microcirculation

Volumn 24, Issue 2, 2001, Pages 111-115

  Vayá, Amparo ^a   Martínez, Martial ^a   Fernández, Angeles ^a   Ripoll, Francisco ^a   Moscardö, Federico ^a   Mira, Yolanda ^a   Aznar, Justo ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Acenocoumarol; Artrial fibrillation; Hemorheology

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLOOD FILTRATION; BLOOD RHEOLOGY; BLOOD VISCOSITY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN TISSUE; MALE; PLASMA VISCOSITY;

ACENOCOUMAROL; ADMINISTRATION, ORAL; ANTICOAGULANTS; ATRIAL FIBRILLATION; BLOOD VISCOSITY; DRUG EVALUATION; ERYTHROCYTE INDICES; FEMALE; FIBRINOGEN; HEMORHEOLOGY; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SAFETY;

EID: 0034994173     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. J. Hirsch, Oral anticoagulant drugs, New Engl. J. Med. 324 (1991), 1865-1875.
2. G.D.O. Lowe, Evaluation of Theological therapy by orally administered drugs, Clin. Hemorheol. 4 (1984), 159-175.
3. G.A. Mayer, Blood viscosity and oral anticoagulant therapy, Am. J. Clin. Pathol. 65 (1976), 402-406.
4. G.D.O. Lowe, Blood rheology and venous thrombosis, Clin. Hemorheol. 4 (1984), 571-588.
5. Chabanel, M.H. Horellou, J. Conard and M. Samama, Red blood cell aggregability in patients with a history of leg vein thrombosis: influence of post-thrombotic treatment, Brit. J. Hematol 88 (1994), 174-179.
6. R. Koppensteiner, A. Moritz, R. Moidl et al., Blood rheology in patients with native heart valve disease and after replace- ment, Am. J. Cardiol. 81 (1998), 250-252.
7. H.L. Reid, A.J. Barnes, P.J. Loch and T.L. Dormandy, A simple method for measuring erythrocyte deformability, J. Clin. Pathol. 29(1976), 855-859.
8. F. Jung, H.G. Roggenkamp, R. Scheider and H. Kiesewetter, Das Kapillarschlauch-Plasmaviskosimeter ein neues Mess- gerät zur Quantifizierung der Blutplasmaviskosität, Biomed. Technik 28 (1983), 249-252.
9. H. Schmid-Schönbein, E. Volger, P. Teitel, H. Kiesewetter, V. Daver and L. Heilmann, New hemorheological techniques for the routine laboratory, Clin. Hemorheol. 2 (1983), 93-105.
10. P. Ruef, J.M.B. Pöschl and O. Linderkamp, The Rheodyn SSD for measuring erythrocyte deformability, Biorheology 32 (1995), 357-358.
11. G. Di Minno and M. Mancini, Measuring plasma fibrinogen to predict stroke and myocardial infarction, Atherosclerosis 10(1990), 1-7.
12. R. Mitusch, J. Siemens, M. Garbe, T. Wagner, A. Scheikhzaden and K. Diederich, Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy, Thromb. Haemostasis 75 (1996), 219-223.
13. G.Y.H. Lip, G.D.O. Lowe, A. Rumpley and EG. Dunn, Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment, Brit. Heart J. 73 (1995), 527-533.
14. J. Eritsland, I. Seljeflot, H. Arnesen, P. Smith and A.B. Westivk, Effects of long-term treatment with warfarin on fibrinogen FPA, TAT, and D-dimer in patients with coronary artery disease, Thromb. Haemostasis 66 (1992), 55-60.
15. G.D.O. Lowe, Blood rheology in arterial disease, Clin. Sei. 71 (1986), 137-146.